Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 116008
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.116008
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.116008
Table 1 Baseline characteristics (n = 627), n (%)/median (interquartile range)
| Variable | Values |
| Age (years) | 47.00 (34.50-55.00) |
| Sex | |
| Male | 438 (69.86) |
| Female | 189 (30.14) |
| ALT (U/L) | 114.00 (39.00-408.50) |
| AST (U/L) | 77.00 (36.00-235.50) |
| GGT (U/L) | 57.00 (28.00-119.00) |
| PLT (109/L) | 130.00 (87.00-173.00) |
| TBIL (μmol/L) | 17.20 (11.00-34.75) |
| ALB (g/L) | 38.20 (34.35-41.85) |
| TP (g/L) | 67.90 (63.70-72.30) |
| APRI | 1.92 (0.83-5.42) |
| GPR | 0.99 (0.44-2.29) |
| FIB-4 | 2.94 (1.49-6.57) |
| AST/ALT | 0.72 (0.50-1.13) |
| NRS2002 | |
| NRS2002 < 3 | 489 (77.9) |
| NRS2002 ≥ 3 | 138 (22.01) |
| Child-Pugh | |
| A | 441 (70.33) |
| B | 108 (17.22) |
| C | 78 (12.44) |
| FibroScan | |
| F0 | 136 (21.69) |
| F1 | 105 (16.75) |
| F2 | 79 (12.6) |
| F3 | 117 (18.66) |
| F4 | 190 (30.3) |
- Citation: Wang CX, Yan P, Lan LJ, Zhao BN, Kang J, Li MQ, Liu DF. Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study. World J Hepatol 2026; 18(5): 116008
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/116008.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.116008